NRX Pharmaceuticals, Inc. Class of Warrant or Right, Outstanding
NRX Pharmaceuticals, Inc. (NRXP) had Class of Warrant or Right, Outstanding of 8.99 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-14
- 2026-06-30: Class of Warrant or Right, Outstanding 8.99M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 9.36M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 9.36M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 9.45M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 8.99M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 9.36M shares 10-Q · filed 2026-08-14 | |
| 2025-12-31 | 9.36M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 9.45M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 9.54M shares 10-Q · filed 2025-08-18 | |
| 2025-03-31 | 9.56M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 7.17M shares 10-Q · filed 2026-08-14 | |
| 2024-09-30 | 5.33M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 4.07M shares 10-Q · filed 2024-11-14 | |
| 2024-03-31 | 4.03M shares 10-Q · filed 2024-11-14 | |
| 2023-12-31 | 3.32M shares 10-K · filed 2026-03-23 | |
| 2023-09-30 | 33.02M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 30.02M shares 10-Q · filed 2023-11-14 | |
| 2023-03-31 | 20.35M shares 10-Q · filed 2023-11-14 | |
| 2022-12-31 | 1.65M shares 10-K · filed 2025-03-14 | 16.48M shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 17.52M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 17.52M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 17.52M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 9.31M shares 10-K · filed 2023-03-31 | |
| 2021-09-30 | 9.31M shares 10-Q/A · filed 2022-08-12 | |
| 2021-06-30 | 8.50M shares 10-Q/A · filed 2022-08-12 | |
| 2021-03-31 | 4.91M shares 10-Q/A · filed 2022-08-12 | |
| 2020-12-31 | 3.08M shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |